NLG802 free base · Synonyms: NLG-802 · NLG 802
NLG802 is a prodrug of indoximod, an orally active indoleamine 2,3-dioxygenase inhibitor.
For research use only. Not for human or veterinary use.
Research area
Cancer
Purity >98%
Stock Inquire
NLG802 structure
CAS No.: 2071683-99-1
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 50 mg | USD 500.00 | BP-02233-50mg | In stock | Get quote |
| 100 mg | USD 750.00 | BP-02233-100mg | In stock | Get quote |
| 250 mg | USD 1,250.00 | BP-02233-250mg | In stock | Get quote |
| 500 mg | USD 1,950.00 | BP-02233-500mg | In stock | Get quote |
| 1 g | USD 3,249.00 | BP-02233-1g | In stock | Get quote |
| 5 g | Inquire | BP-02233-5g | In stock | Inquire |
Need another size or custom synthesis? Request a quote.
Description
NLG802 is a prodrug of indoximod, an orally active indoleamine 2,3-dioxygenase (IDO) inhibitor.
Biological activity
NLG802 is a prodrug of indoximod, an orally active indoleamine 2,3-dioxygenase (IDO) inhibitor.
Identifiers
- SMILES
-
CC(C)C[C@H](N)C(N[C@@H](C(OCC)=O)CC1=CN(C)C2=CC=CC=C12)=O.Cl - InChIKey
-
PXFDVONNVFXYEP-MCJVGQIASA-N
Specifications
- MW (average)
- 395.9240
- Formula
- C20H30ClN3O3
- CAS No.
- 2071683-99-1
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder 4°C, sealed storage, away from moisture; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
- In vitro
- DMSO : 250 mg/mL
Documents
References
[1]. Kumar S, et al. Discovery of indoximod prodrugs and characterization of clinical candidate NLG802. Eur J Med Chem. 2020 Jul 15;198:112373.
Same research area
Search Cancer- BP-01858A Derazantinib hydrochloride salt · >98%
- BP-01861A Nirogacestat dihydrobromide salt · >98%
- BP-01900A IACS-010759 HCl salt · >98%
- BP-01923 Avapritinib free base · >98%
- BP-01924 BLU-554 free base · >99%
- BP-01925 ACY-1083 free base · >98%
- BP-01927 PHGDH-IN-5 free base · >98%
- BP-01928 Bortezomib free base · >99%